International Journal of Hematology-Oncology and Stem Cell Research 2017. 11(2):92-95.

Prevalence of G6PD Deficiency in Children with Hepatitis A
Ghasem Miri-Aliabad, Ali Khajeh, Tooran Shahraki

Abstract


Introduction: Hepatitis A virus is the most prevalent viral hepatitis. It is globally a major public health problem with different clinical symptoms. This study aimed at investigating the clinical findings and prevalence of glucose 6-phosphate dehydrogenase (G6PD) deficiency in children with hepatitis A.

Materials and Methods: In this prospective study, demographical information, clinical findings, and G6PD level of hepatitis A patients, who were visited at Pediatric Hematology clinic, were entered into the database. The diagnosis of hepatitis A infection was based on the presence of anti-HAV IgM antibody. The activity of G6PD enzyme was measured with florescent spot test.

Results: Of the 117 children with hepatitis A, 52 (44.4%) were male and 65 (55.6%) were female. The mean age of these patients was 2.79±5.39 years. The most prevalent clinical manifestations were dark yellow urine and anorexia. G6PD deficiency was observed in 26 (26.3%) out of 99 patients whose G6PD levels were measured.

Conclusion: Given the high prevalence of G6PD deficiency in this study, the measurement of G6PD level along with other liver and biochemical markers in areas with endemic hepatitis A is recommended. In addition, it is recommended that patients undertake precise monitoring for hemolysis and renal function.

 


Keywords


Children, Hepatitis A, G6PD Deficiency

Full Text:

PDF

References


CioccaM.Clinical course and consequences of hepatitis A infection. Vaccine. 2000;18 Suppl 1:S71-4.

Taghavi SA, Hosseini Asl MK, Talebzadeh M, et al.Seroprevalence study of hepatitis A virus in Fars province, southern Iran. Hepat Mon. 2011;11(4):285-8.

Jacobsen KH, Koopman JS. The effects of socioeconomic development on worldwide hepatitis A virus seroprevalence patterns. Int J Epidemiol. 2005;34(3):600–9.

Almuneef MA, Memish ZA, Balkhy HH,et al.Epidemiologic shift in the prevalence of hepatitis A virus in Saudi Arabia: A case for routine hepatitis A vaccination. Vaccine 2006;24:5599–603.

Kiyohara T, Sato T, Totsuka A, et al. Shifting seroepidemiology of hepatitis A in Japan 1973-2003. Microbiol Immunol 2007;51:185–91.

Ikram N, Hassan K and Tufail F. Hepatitis associated autoimmune haemolytic anaemia. Int J Path 2004; 2:44-46.

Fasola FA, Otegbayo JA, Abjah UMA, et al. Haematological Parameters in Nigerians with Acute Viral Hepatitis. Nigerian Journal of Gastroenterology and Hepatology 2009; 1(1): 27-31.

Nishioka SD. Aplastic anemia and viral hepatitis: a second look. Hepatology 1997; 25: 125

Gumba SC، Chopra S. Hepatitis C: a multifactorial disease, review of extrahepatic manifestations. Ann Intern Med. 1995; 123:615-620.

Nakhaee A, Salimi S, Zadehvakili A, et al. The Prevalence of Mediterranean Mutation of Glucose-6-Phosphate Dehydrogenase (G6PD) in Zahedan. Zahedan J Res Med Sci. 2012;14(3):39-43.

Maleki R, Shariati A, Mirzaei N, Mirzaei A. Prevalence of beta thalassemia minor, iron deficiency and glucose-6-phosphate dehydrogenase deficiency in Iranian boy’s primary schools in Yasuj . Life Sci J 2014;11(9s):505-508

Sodeinde O. Glucose-6-phosphate dehydrogenase deficiency. Baillieres Clin Haematol. 1992; 5(2):367-82.

Cappellini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet. 2008; 371(9606):64-74.

Ho L, John RM. Understanding and Managing Glucose-6-Phosphate Dehydrogenase Deficiency. The Journal for Nurse Practitioners. 2015;11(4):443-450.

Cocco P, Todde P, Fornera S, et al. Mortality in a cohort of men expressing the glucose-6-phosphate dehydrogenase defi ciency. Blood. 1998; 91(2): 706–09.

Laffan MA and Bradshaw AE. Investigation of haemostasis :In Dacie JV, Lewis SM .Practical Haematolog y. Eight Edition.London Churchhill Livingstone. 1999; 297-315.

Fellermann K, Stange EF. Chronic hepatitis C, common variable immunodeficiency and autoimmune hemolytic anemia. Coincidence by chance or common etiology?. Hepatogastroenterology. 2000 ;47(35):1422-4

Lyons DJ, Gilvarry JM, Fielding JF. Severe haemolysis associated with hepatitis A and normal glucose-6-phosphate dehydrogenase status. Gut. 1990;31:838–839.

Tibble JA, Ireland A, Duncan JR. Acute autoimmune haemolytic anaemia secondary to hepatitis A infection. Clin Lab Haematol.1997; 19 (1) :73–75.

Abid S, Khan AH. Severe hemolysis and renal failure in glucose-6-phosphate dehydrogenase deficient patients with hepatitis E. Am J Gastroenterol. 2002 ; 97(6):1544–7.

Huo TI, Wu JC, Chiu CF, et al.Severe hyperbilirubinemia due to acute hepatitis A superimposed on a chronic hepatitis B carrier with glucose-6-phosphate dehydrogenase deficiency. Am J Gastroenterol. 1996; 91:158–159.

Gotsman I, Muszkat M. Glucose-6-phosphate dehydrogenase deficiency is associated with increased initial clinical severity of acute viral hepatitis A. J Gastroenterol Hepatol. 2001;16:1239–1243.

Hosnut FO, Ozcay F, Bayrakci US, et al. Etiology of hemolysis in two patients with hepatitis A infection: glucose-6-phosphate dehydrogenase deficiency or autoimmune hemolytic anemia. Eur J Pediatr. 2008;167(12):1435-9.


Refbacks

  • There are currently no refbacks.


Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.